News – Next generation gene therapy vectors https://raaven.se Tue, 14 Jan 2025 15:48:05 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 https://raaven.se/wp-content/uploads/2023/05/favicon-150x150.png News – Next generation gene therapy vectors https://raaven.se 32 32 rAAVen and Cellevate Partner on AAV Library Testing https://raaven.se/raaven-and-cellevate-partner-on-aav-library-testing/ Wed, 28 Aug 2024 12:38:00 +0000 https://raaven.se/?p=10812

Together with fellow SmiLe Incubator alumni community member Cellevate, rAAVen Therapeutics announces the start of a shared project. Within this project rAAVen will design and produce a targeted AAV library, for testing and assessment of the Cellevate3dTM nanofiber microcarrier.

]]> rAAVen Welcomes Yuriy Pomeshchik as Director of In Vitro https://raaven.se/raaven-welcomes-yuriy-pomeshchik-as-director-of-in-vitro/ Thu, 01 Aug 2024 13:15:00 +0000 https://raaven.se/?p=10830




rAAVen Therapeutics announces the hiring of Yuriy Pomeshchik MD, PhD as Director of In Vitro. Before joining rAAVen, Yuriy held a position as Associate Researcher at Lund University. 

]]> rAAVen to Present at #ASGCT2024 and Myrtelle Symposium https://raaven.se/raaven-to-present-at-asgct2024-and-myrtelle-symposium/ Mon, 13 May 2024 13:16:00 +0000 https://raaven.se/?p=10833

rAAVen Therapeutics is pleased to share the news on our participation in this year’s  #ASGCT2024, and the symposium held by Myrtelle, Inc., where we will be presenting the latest findings on AAVs targeting oligodendrocytes. 

]]> rAAVen Partners with Prevail to Advance AAVs for Neurological Disorders https://raaven.se/raaven-partners-with-prevail-to-advance-aavs-for-neurological-disorders/ Tue, 02 Apr 2024 13:19:00 +0000 https://raaven.se/?p=10835

rAAVen Therapeutics is excited to announce a new partnership with Prevail Therapeutics to develop novel adeno-associated virus (AAV) capsids for disorders of the nervous system. (link)

]]> rAAVen Appoints Magnus Henriks as Chief Executive Officer https://raaven.se/raaven-appoints-magnus-henriks-as-chief-executive-officer/ Mon, 01 Apr 2024 15:12:00 +0000 https://raaven.se/?p=10885

rAAVen Therapeutics has hired Magnus Henriks as the Chief Executive Officer. Prior to joining rAAVen, Magnus has had leading positions in various commercial companies. 

]]> rAAVen and Myrtelle Expand Partnership for Capsid Validation https://raaven.se/raaven-and-myrtelle-expand-partnership-for-capsid-validation/ Thu, 18 Jan 2024 15:14:00 +0000 https://raaven.se/?p=10888

rAAVen Therapeutics has gone into an agreement, for a continuous partnership with Myrtelle, Inc. In the new collaboration rAAVen will validate a defined number of capsids from the previously performed oligodendrocyte screening assay. 

]]> Lena Mårtensson Joins rAAVen Board of Directors https://raaven.se/lena-martensson-joins-raaven-board-of-directors/ Tue, 07 Nov 2023 15:18:00 +0000 https://raaven.se/?p=10892

Lena Mårtensson has been assigned to the rAAVen Therapeutics Board of Directors. Lena has an extensive background within Life Science, with multiple project and business development roles in i.e AstraZeneca and Pharmacia/Pfizer. 

]]> rAAVen to Present at Viral Vector Summit in Amsterdam https://raaven.se/raaven-to-present-at-viral-vector-summit-in-amsterdam/ Sat, 10 Jun 2023 15:21:00 +0000 https://raaven.se/?p=10894

rAAVen Therapeutics will participate in the Viral Vector Formulation Process & Development Summit in Amsterdam 11-13 June. Our CSO, Patrick Aldrin-Kirk, will present the rAAVen platform, and what makes us the go to alternative when it comes to novel AAV capsid engineering. (link)

]]> rAAVen and PCI Biotech Launch Photochemical Lysis Project https://raaven.se/raaven-and-pci-biotech-launch-photochemical-lysis-project/ Wed, 24 May 2023 15:24:00 +0000 https://raaven.se/?p=10896

rAAVen Therapeutics is pleased to announce a new joint Photochemical Lysis project with PCI Biotech. In the project, rAAVen will develop and produce AAV, as well as perform research.

]]> Patrick Aldrin-Kirk Joins rAAVen as Chief Scientific Officer https://raaven.se/patrick-aldrin-kirk-joins-raaven-as-chief-scientific-officer/ Tue, 01 Nov 2022 15:25:00 +0000 https://raaven.se/?p=10898

rAAVen Therapeutics hires Patrick Aldrin-Kirk, PhD as its new Chief Scientific Officer. Before joining rAAVen, Patrick did his postdoc and held a position as Associate Professor at Copenhagen University, Denmark. 

]]>